PIGMENTED SKIN LESIONS IN CHILDREN: CONGENITAL MELANOCYTIC NEVUS, PEDIATRIC LONGITUDINAL MELANONYCHIA, AND PEDIATRIC MELANOMA
View/ Open
tsaiserena_458848_19605103_MasterThesis_MMSCI_final.pdf (1.250Mb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Tsai, Serena Yun-Chen
Metadata
Show full item recordCitation
Tsai, Serena Yun-Chen. 2024. PIGMENTED SKIN LESIONS IN CHILDREN: CONGENITAL MELANOCYTIC NEVUS, PEDIATRIC LONGITUDINAL MELANONYCHIA, AND PEDIATRIC MELANOMA. Master's thesis, Harvard Medical School.Abstract
Background: Considering childhood is a prime period for nevogenesis and given the ectodermal origin of melanocytes and neural tissues, congenital or early-onset nevi might be associated with neurological and developmental disorders later in life.Methods: This was a population-based cohort study retrieving electronic health records from a United States claims database. Pediatric patients (under 18 years) with at least 1 diagnosis of CMN before 3 years of age were included. Unexposed controls were individuals who had encountered health services before 3 years of age without any recording of the aforementioned diagnosis; these were matched for demographics using a 1:1 propensity score matching method. The primary composite outcome was the incidence of subsequently documented neurological and developmental diagnoses, including CNS cancers, seizures, hydrocephalus, cerebral palsy, developmental (speech/learning/motor) delay, attention-deficit hyperactivity disorder, autism spectrum disorder, and intellectual disability. The secondary outcomes included individual components of the primary composite outcome.
Results: A total of 30,021 patients with CMN and 2,113,232 unexposed controls were identified, with 30,005 participants after matching in both groups. Individuals with early-onset melanocytic nevi exhibited significantly higher risks of new-onset neurological and developmental diagnoses (HR = 1.43; 95% CI = 1.39-1.48; p 0.001), including hydrocephalus (HR = 1.50; 95% CI = 1.07-2.11; p = 0.019), developmental speech/learning/motor delay (HR = 1.59; 95% CI = 1.31-1.92; p 0.001), autism spectrum disorder (HR = 1.13; 95% CI = 1.02-1.25; p = 0.016), and intellectual disability (HR = 1.31; 95% CI = 1.02-1.68; p = 0.034). After Benjamini-Hochberg correction, the primary composite outcome, hydrocephalus, developmental speech/learning/motor delay, and autism spectrum disorder remained statistically significant.
Conclusion: Our findings identify an association of neurologic and developmental disease and the diagnosis of nevi in early childhood (before age 3 years), which provides new information regarding potential comorbid diagnoses, rationale for screening in clinical practice, and important signals for further study.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37378396
Collections
Contact administrator regarding this item (to report mistakes or request changes)